FSD Pharma Continues to Add Expert Advisors Amid Buildout of Massive Facility -- CFN Media

About this update from Quantum Biopharma Ltd. Subordinate Voting Shares Class B

[{"type":"text","content":"FSD Pharma Continues to Add Expert Advisors Amid Buildout of Massive Facility -- CFN MediaSeattle, Washington--(Newsfile Corp. - June 14, 2019) - CFN Media Group (\"CFN Media\"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF). The company has been focused on building out its board of directors and advisory board since becoming a full Canadian licensed producer earlier this year. After receiving its cultivation license in 2017, the company began work on a massive cultivation facility that could house nearly four million sq. ft. on 70 acres of land before receiving its sales license in April of this year.By building an independent board to oversee governance and provide expertise, the company is building a solid foundation as it looks to become a medical cannabis leader.Noteworthy New AppointmentsFSD Pharma recently announced the addition of James A. Datin and Robert J. Ciaruffoli, CPA, to its Board of Directors. Both of these board members bring significant industry experience and connections at some of the largest companies in their respective sectors.Mr. Datin is the President and CEO of BioAgilytix, a leading global bioanalytical contract research organization (CRO). Since becoming CEO, he has been instrumental in growing the company's customer base and capacity, including an expansion into Europe. BioAgilytix was recently acquired by a private equity fund after being named to the Inc. 5000 list of the Fastest Growing Private Companies in America six times.Mr. Ciaruffoli is the co-founder of Broad Street Angels, which is the largest angel investor network in the Philadelphia region with over 100 members. As a CPA, he also served as Chairman and CEO of ParenteBeard/Baker Tilly accounting and advisory firm. He orchestrated the merger of ParenteBeard and Baker Tilly in 2014 to create the 12th largest U.S. accounting and advisory firm.FSD Pharma also added two prominent cannabis researchers to its scientific advisory board as it looks to solidify its footprint in the medical side of the industry. The two new board members join an existing team that brings widespread expertise.Dr. Ziva Cooper, Ph.D., is the Research Director of UCLA's Cannabis Research Initiative in the Semel Institute for Neur...

More updates from Quantum Biopharma Ltd. Subordinate Voting Shares Class B